Metformin beneficial tool for diabetic periodontitis through amelioration of oxidative stress Dr. Kamal Kant Kohli5 Aug 2023 9:45 AM ISTChina: A recent study published in the journal Genes & Diseases has provided new evidence that metformin is a potential drug for periodontitis...
Akums gets approval for triple combination diabetes treatment Ruchika Sharma27 July 2023 4:50 PM ISTDelhi: Akums Drugs and Pharmaceuticals Limited has secured approval for its triple combination diabetes treatment. Sitagliptin 100, Pioglitazone 15...
Akums Pharma Gets CDSCO Panel Nod To Manufacture, Market Antidiabetic FDC Drug Dr. Divya Colin9 July 2023 6:00 PM ISTNew Delhi: Noting that the antidiabetic fixed-dose combination (FDC), Sitagliptin Phosphate Monohydrate 100mg/100mg plus Pioglitazone 15mg/15mg plus...
Dapagliflozin, a feasible alternative to sulphonylureas as an add-on after metformin failure in type 2 diabetes patients Medha Baranwal24 Jun 2023 11:15 AM ISTKorea: Dapagliflozin is safe and well-tolerated and, therefore, appears to be a more favourable alternative to sulphonylureas as an add-on therapy...
FDA approves new oral therapy for treatment of Type 2 Diabetes in children Dr. Kamal Kant Kohli22 Jun 2023 9:45 AM ISTUSA: The US Food and Drug Administration (FDA) has approved empagliflozin (Jardiance, Boehringer Ingelheim) and empagliflozin combined with metformin...
SGLT2 inhibitors, metformin tied to prolonged survival in type 2 diabetes compared to other drugs Medha Baranwal17 Jun 2023 11:15 AM ISTSwitzerland: A recent study has shown that current first-line antidiabetic medication, SGLT2 inhibitors, or metformin, raises the survival probability...
Diabetes drug metformin can prevent long COVID in patients with COVID-19 Dr. Kamal Kant Kohli12 Jun 2023 11:00 AM ISTUSA: Diabetes drug metformin can reduce long COVID incidence in COVID-19 patients, says a recent study published in The Lancet Infectious...
Eris Lifesciences Gets CDSCO Panel Nod To Manufacture, Market PCOS drug combination Dr. Divya Colin11 Jun 2023 5:45 PM ISTNew Delhi: Eris Lifescience has got the go-ahead from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control...
Alkem Gets CDSCO Panel Nod to Study Antidiabetic FDC Drug Dr. Divya Colin6 Jun 2023 6:00 PM ISTNew Delhi: The drug major Alkem Laboratories has got the green signal from the Subject Expert Committee (SEC) functional under Central Drug Standard...
Genetic variation linked to treatment response to commonly prescribed type 2 diabetes medication Dr. Kamal Kant Kohli5 Jun 2023 9:45 AM ISTUSA: The Massachusetts General Hospital (MGH) researchers have identified genetic variants associated with response to glucose-lowering medications:...
Novel triple-drug FDC superior to dual combination in type 2 diabetes patients poorly controlled with metformin Medha Baranwal2 Jun 2023 11:30 AM ISTIndia: A recent study has shown a triple-drug fixed-dose combination (FDC) of sitagliptin + dapagliflozin + metformin ER to be superior to dual...
Akum Gets CDSCO Panel Nod to Study Antidiabetic FDC Drug Dr. Divya Colin28 May 2023 6:00 PM ISTNew Delhi: The drug major Akum Pharmaceuticals has got the green signal from the Subject Expert Committee (SEC) functional under the Central Drug...
